In The News
Medidata Solutions' products are creating a buzz in the scientific and IT communities. Here are just a few stories highlighting recent successes.2012
Westat, an employee-owned research corporation, recently introduced Medidata Rave clinical data management services to support cancer Cooperative Groups as part of the Cancer Trials Support Unit (CTSU), a program of the National Cancer Institute (NCI). Westat presented at the Americas Medidata User Group (A-MUG) in May to share its Rave-related skills and approaches.
Read
The New York Times “The Boss” column features Medidata president Glen de Vries, highlighting how ballroom dancing has impacted his approach to business and helped him lead Medidata to its market-leading position today.
Read
The Clinical Data Interchange Standards Consortium (CDISC) announces the release of the Protocol Representation "Toolkit," a standard format for study protocol data designed to save time and resources. Medidata Solutions will be providing the underlying technology for the Protocol Representation Model (PRM) Wizard, available in the next version.
Read
In this April eCliniqua feature, Medidata senior business consultant Jessica Dolfi examines how technological developments can streamline site negotiation processes to accelerate site budgeting and contracting.
Read
Applied Clinical Trials online in April features a Medidata Insights™ benchmark for data correction. Part of a monthly series highlighting industry metrics, this edition focuses on the remarkably low rate of post-capture data correction during clinical trials.
Read
Forbes spotlights Medidata Solutions for its market leadership in software for clinical trials.
Read
In this April PharmaVOICE feature about the evolution of technology in clinical trials, Medidata’s vice president of product management Rick Piazza discusses best practices for integrating data, enabling communications and optimizing clinical trial operations methodology.
Read
In its inaugural “Top 10 Biotech Techies” list, FierceBiotech honors Medidata president Glen de Vries and profiles him as builder of the clinical trial cloud.
Read
FierceBiotechIT reviews Arlene Weintraub’s profile on Medidata in Xconomy and a report from TheStreet, illustrating how the company is being “lauded on Wall Street.”
Read
Glenn Watt, Medidata’s vice president of information security and privacy, shares six key steps to reducing information security costs while ensuring sufficient risk controls in Information Management.
Read
Applied Clinical Trials online in March features Medidata Insights™ benchmarks for form design. Part of a monthly series highlighting industry metrics, this edition highlights a surprising lack of correlation between eCRF design timelines and the rate of eCRF reuse.
Read
Xconomy New York editor and veteran healthcare and life sciences writer Arlene Weintraub highlights how “Medidata Gains Raves on Wall Street,” driven by increasing demand for its cloud-based clinical development solutions and the vision and innovation of president Glen de Vries and CEO Tarek Sherif.
Read
In a March ComputerWorld feature examining agile development methods and outsourcing, Medidata’s senior vice president of research and development Andrew Newbigging discusses the company’s transition to agile and why developing in-house was the better strategy for meeting customer needs.
Read
Applied Clinical Trials online features a Medidata Insights™ benchmark on geographic shifts in enrollment. This unexpected trend in global subject enrollment was posted in February as part of a monthly series highlighting industry metrics.
Read
FierceBiotech IT highlights Medidata as “the cloud for clinical data” in this January article featuring president Glen de Vries’ Q&A in Bio-IT World.
Read
Applied Clinical Trials online features a Medidata Insights™ benchmark on source data verification, posted in January as the first of a monthly series highlighting industry metrics.
Read
Medidata president Glen de Vries chats with Bio-IT World’s chief editor about the history of the company and the focus on optimizing clinical trials from concept to conclusion, in this January Q&A on the state of e-clinical technologies.
Read
2011
In the fall issue of The Security Journal, Medidata's vice president of information security and privacy, Glenn Watt, discusses how organizations can view information security strategically in software development without falling victim to high costs.
Read
In the December issue of Journal for Clinical Studies, Medidata authors Jessica Dolfi and Sondra Pepe discuss the impact of the impending Sunshine Act on clinical trial sponsors.
Read
In eCliniqua’s December issue, Medidata’s Michelle Marlborough, director of product management, and Joshua Pines, senior product marketing manager, encourage protocol authors to think of themselves as data archaeologists, analyzing previous research to uncover and replicate best practices.
Read
Medidata’s vice president of partnerships and alliances, Graham Bunn, notes the qualities of effective CRO-sponsor relationships in Life Science Leader’s December issue.
Read
Medidata director of product marketing Stan Haavik, traces the development of interactive response technology (IRT) systems used in clinical trials for randomization, supply planning and implementation, in the December issue of Applied Clinical Trials.
Read
In the December issue of European Pharmaceutical Review, Medidata’s senior director of development Jeffrey Cohen and senior product marketing manager Joshua Pines discuss the standards created to help simplify integration between clinical technology solutions, and the external systems managing EHRs and medical images.
Read
ComputerWorld includes Medidata in a December article highlighting 10 selected firms that are looking to hire tech workers.
Read
Patrick Chassaigne, director, late phase solutions, explores the patients role in Phase IV studies and registries, in the November/December Year in Preview issue of PharmaVOICE. Vice president of clinical solutions Jeffrey Handen also weighs in on engaging the patient as a drug development partner and president Glen de Vries highlights three top trends impacting R&D.
Read (Patrick Chassaigne) | Read (Jeffrey Handen) | Read (Glen de Vries)
In a PharmExec guest blog post, Medidata director of late phase solutions Patrick Chassaigne discusses ways to drive patient participation in post-approval studies.
Read
In the autumn 2011 issue of International Clinical Trials, Medidata’s vice president of data operations Lori Shields discusses the importance of new technological tools that help sponsors and sites meet their budget needs and increase study efficiency.
Read
Medidata’s director of product management Michelle Marlborough comments on the importance of structured protocol designs to minimize costly mid-study amendments in the October 2011 issue of CenterWatch Monthly.
Read
Medidata's acquisition of Clinical Force, featured in the September issue of PharmaVOICE, leads to new clinical trial management solutions (CTMS) offerings. The issue also highlights product announcements for Medidata Standards Accelerator, Insights and Coder.
Read
Medidata senior vice president of development Andrew Newbigging named to PharmaVOICE 100 for his innovative efforts in clinical technology integration and commitment to advancing industry standards.
Read
Medidata’s vice president of data operations Lori Shields addresses the variance in clinical trial overhead rates across sites in the July issue of The CenterWatch Monthly.
Read
In a PharmaVOICE interview at the DIA Annual Meeting in Chicago, Medidata president Glen de Vries discusses ways to tackle challenges across the end-to-end clinical development process.
View
Medidata vice president of partnerships and alliances Graham Bunn discusses the recent acquisition of Clinical Force with Outsourcing-Pharma senior editor Nick Taylor live from the DIA Annual Meeting in Chicago.
View
Medidata director of product marketing Stan Haavik discusses the importance of process efficiency in clinical trial randomization in the June issue of PharmaVOICE.
Read
Medidata executive vice president of product and marketing Lineene Krasnow comments on new approaches to address the challenges of growing protocol complexity in the June issue of PharmaVOICE.
Read
Medidata vice president of product management Rick Piazza discusses the value of integration to maximize the benefits of clinical development technologies in the June issue of PharmaVOICE.
Read
In the summer issue of European Pharmaceutical Contractor, Medidata senior product marketing manager Joshua Pines discusses how life science organizations can maximize the impact of EDC adoption by revisiting their internal processes and analytics tools.
Read
Boston University’s Dr. Iain Cockburn discusses the use of Medidata’s trial planning data in a National Bureau of Economic Research study analyzing the increasing costs of clinical trials in this May article from ClinPage.
Read
Medidata vice president of partnerships and alliances Graham Bunn discusses CRO industry trends, including the importance of strategic relationships with sponsors, in the May issue of Contract Pharma.
Read
The Cancer Letter interviews Medidata president Glen de Vries about the implementation of Medidata Rave by the National Cancer Institute Cooperative Groups. Published with permission from The Cancer Letter.
Read
CWWeekly's “Insider Insights” spotlights Medidata in an in-depth interview with Medidata president Glen de Vries.
Read
Medidata associate product manager Keyur (Kevin) Shroff discusses six steps to streamlining the contracting of sites for clinical studies in the March issue of Journal for Clinical Studies.
Read
Medidata director of late phase solutions Patrick Chassaigne weighs in on the growing importance of observational research in the March issue of R&D Directions.
Read
Medidata vice president of regulatory policy Pat Beers Block and senior product director Steve Young provide commentary on the high cost and questionable impact of 100% SDV in the February issue of The CenterWatch Monthly.
Read
Medidata senior director of product marketing Ron Rubinstein discusses why EDC offers an elegant solution to reducing the burden of SAE reporting for both sites and sponsors in the January/February issue of Bio-IT World.
Read
2010
Medidata business consultant Jessica Dolfi explains how to optimize a site budget in a diverse and rocky world in the December issue of Scrip Clinical Research.
Read
Medidata senior product director Steve Young and director of strategic initiatives Ashwin Mundra equip clinical organizations on the right tools to execute risk-based site monitoring in the November/December issue of VIEW on E-Solutions.
Read
ClinPage reports on October 22 on Medidata's EDC enhancements and how the company continues to innovate briskly.
Read
Medidata vice president of channel sales and head of EMEA Steve Heath focuses on Australia as an emerging global clinical research destination in the September issue of the Journal for Clinical Studies.
Read
Medidata senior product director Steve Young and director of strategic initiatives Ashwin Mundra discuss risk-based site monitoring and partial source document verification as the new paradigm in the September issue of European Pharmaceutical Contractor.
Read
Peking University Clinical Research Institute partners with Medidata to support China's Drug Innovation and Development initiative.
Read
Medidata president Glen de Vries explains to PharmaVOICE on the show floor of the DIA Annual Meeting how Software as a Service (SaaS) can improve the clinical development process as well as optimize sponsors' R&D investments.
View
Medidata vice president of operational excellence Douglas Bain provides insight on the future of e-sourcing in a September 21 article by eCliniqua.
Read
Medidata director of strategic initiatives Ashwin Mundra discusses the new paradigm in site monitoring in the September issue of Life Science Leader.
Read
Medidata vice president of partnerships Graham Bunn named to PharmaVOICE 100 as a CRO and technology partnership visionary and for inspirational industry leadership.
Read
Medidata vice president of operations Lori Shields and manager of data quality and analytics Rafael Campo discuss reimbursement and protocol complexity trends in the June issue of VIEW on Clinical Operations.
Read
Medidata business consultant Jessica Dolfi, manager of data quality and analytics Rafael Campo and other industry experts share how study managers can master currency fluctuations in global clinical trials in the June issue of Applied Clinical Trials.
Read
FierceBiotech IT reports on June 18 the unveiling of Medidata Balance, a randomization and trial supply management solution, at the Drug Information Association (DIA) meeting.
Read
Medidata president Glen de Vries discusses two new products announced at the DIA Meeting in Washington, D.C., with Bio-IT World on June 16.
Read
Drug Discovery & Development reports on June 16 that Medidata and Aris Global announced the data sharing for EDC and Safety Report Systems.
Read
ClinPage reports on June 15 that the Medidata and SAS alliance provides strong clinical data custody.
Read
Medidata president Glen de Vries talks about running a business by predicting industry needs for ten years in the future and the excitement of taking the company through an IPO during the most challenging economic climate in history in the June issue of Scrip Clinical Research.
Read
Medidata vice president of partnerships and alliances Graham Bunn provides commentary on how CROs are riding the R&D recession wave in a CRO industry update in the June issue of Contract Pharma.
Read
Applied Clinical Trials reports on June 3 that Medidata welcomed the first Australian CRO to the ASPire to Win channel partner program.
Read
Medidata senior client relations specialist Sondra Pepe provides insight on managing a global clinical trial in a June 1 article by Applied Clinical Trials.
Read
FierceBiotech IT reports on May 14 that Medidata and Aris Global have integrated the ARISg solution for pharmacovigilance and clinical safety with Medidata Rave for electronic data capture, management and reporting.
Read
Medidata client services principal Thomas Ermlich explains how companies can maximize their eClinical strategies through process optimization, technology implementation and industry knowledge in the spring issue of European BioPharmaceutical Review.
Read
FierceBiotech IT reports on April 10 that City of Hope selected Medidata Rave for its internal clinical trials after evaluating ten electronic data capture solutions.
Read
Medidata vice president of alliances Anne Zielinski discusses what makes the right menu for clinical trials technology in the April issue of Life Science Leader magazine.
Read
Medidata vice president of information security and privacy Glenn Watt shares lessons from the trenches of clinical development technology for cloud computing security in the January issue of Bio-IT World.
Read
2009
Medidata vice president of implementation services David Gemzik and other industry experts discuss the CDISC protocol representation model for optimizing clinical research via standardization in Volume 4 of Drug Development.
Read
Roche explains how it managed the successful introduction of its new EDC system, Medidata Rave, in the autumn issue of Data Matters, an ACDM newsletter.
Read
Medidata vice president of implementation services David Gemzik offers tips for a healthy clinical trial
with the help of high-quality protocol development programs in the December issue of European Pharmaceutical Contractor.
Read
Medidata vice president of alliances Anne Zielinski examines if Contract Research Organizations (CROs) and Electronic Data Capture (EDC) are a match made in heaven or an uneasy alliance in the November/December issue of Contract Pharma.
Read
Medidata vice president of implementation services David Gemzik and senior product marketing manager Sean Cheng explain why sponsors need an integrated, closed-loop clinical process in the November issue of VIEW on E-Solutions.
Read
Medidata vice president and head of EMEA Steve Heath and senior director of quality assurance Tony Hewer discuss how technology can aid in the relationship between society, regulators and the life sciences industry in the November issue of Life Science Leader.
Read
Medidata vice president and head of EMEA Steve Heath explains how small and mid-sized biotech and pharmaceutical companies can continue to build an eClinical strategy in today's economy in the autumn issue of the Journal for Clinical Studies.
Read
Medidata vice president and head of EMEA Steve Heath provides the editorial advisory keynote for the July issue of the Journal for Clinical Studies.
Read
Medidata vice president Lori Shields honored in PharmaVOICE 100 for innovation, creativity and inspirational leadership.
Read
Medidata vice president of implementation services Mukhtar Ahmed looks at the growth and challenges of the Asia Pacific region in European Pharmaceutical Contractor.
Read
Medidata senior client relations specialist Sondra Pepe provides an overview of the proposed Sunshine Act legislation and how pharmaceutical, biotechnology and medical device companies can prepare for the potential impact of these new federal requirements in Pharmaceutical Executive.
Read
Medidata explains how electronic protocol solutions can save time and costs for sponsors in eCliniqua.
Read
Medidata senior director of product marketing Ron Rubinstein and president of MonitorForHire.com, Scott Freedman, explain how EDC has changed clinical monitoring in VIEW on Clinical Operations.
Read
Medidata president Glen de Vries and SAS global director of health and life sciences market segments Jason Burke discuss the current state of health business innovation, particularly around providing solutions for clinical trials and drug development in a Bio-IT World podcast.
Read
Medidata director of late phase solutions Patrick Chassaigne and vice president of quality assurance Fran Nolan explore how EDC can meet the regulatory challenges of post-approval research in the Good Practice Clinical Journal.
Read
AstraZeneca's use of Medidata Rave receives honorable mention from Bio-IT World magazine's fifth Best Practices Awards program.
Read
Medidata head of EMEA Steve Heath provides commentary on India as an emerging market for clinical trials in R&D Directions.
Read
Medidata director of late phase solutions Patrick Chassaigne explains how EDC can help power post-marketing studies in the Journal for Clinical Studies.
Read
Medidata vice president of global CRO partnerships Graham Bunn defines what global means and provides commentary on global development for drug developers in PharmaVOICE.
Read
Medidata general manager of Trial Planning Solutions Ed Seguine explains why it's time to change protocol design and how eProtocol will provide a radical shake-up of old processes and lead to improved productivity in International Clinical Trials.
Read
Medidata supports the efforts of the American National Standards Institute (ANSI) in facilitating the use of electronic health information to support global clinical research activities.
Read
Medidata selected as finalist for the Software & Information Industry Association's (SIIA) 24th Annual CODiE Awards, which celebrate outstanding achievement and vision in the software, digital information and education technology industries. Medidata Rave's Web Services API was among 5 finalists nominated in the Best Medical and Health Information Product category.
Read
Medidata vice president of global CRO partnerships Graham Bunn discusses the world of opportunity for contract research companies in choosing sites for clinical trials in R&D Directions.
Read
Medidata vice president of operations for Trial Planning Solutions Lori Shields provides expert commentary on process improvements for investigator payments in PharmaVOICE.
Read
Medidata senior director of product marketing Ron Rubinstein offers three key ingredients to cost effective clinical system interoperability in Bio-IT World.
Read
Bio-IT World explains how Medidata avoids the pitfalls of EDC training.
Read
Medidata head of EMEA Steve Heath takes a look at electronic data capture solutions in Next Generation Pharmaceuticals.
Read
2008
Alan Louie, research director at Health Industry Insights, an IDC company, offers his perspective on how Medidata brings intelligent design to clinical trials.
Read
Senior research fellow at the Tufts Center for the Study of Drug Development Ken Getz and Medidata general manager of trial planning solutions Ed Seguine address the cause, not symptoms, of rising clinical trial delays and costs in a Bio-IT World podcast.
Listen
Medidata senior vice president of development Keith Howells explores the opportunities, risks and technical requirements needed for an integrated EDC environment in IDrugs.
Read
Medidata vice president of knowledge management Daniel Mudgett and manager of knowledge management Ashwin Mundra discuss how integrated eLearning enables efficient and streamlined global trials in VIEW on E-Solutions.
Read
Bio-IT World discusses how Medidata spurs innovation with Developer Central.
Read
Medidata vice president of global operational excellence Doug Bain provides commentary on CDASH as the final piece in the end-to-end eClinical interoperability puzzle in Clinical Trials Today.
Read
Medidata vice president of integrations development Andrew Newbigging discusses how ePRO and EDC are perfect together in Applied Clinical Trials.
Read
Medidata general manager of trial planning solutions Ed Seguine senior data analytics specialist, Rafael Campo, and other industry experts assess protocol complexity and the impact of protocol design changes on clinical trial performance in the American Journal of Therapeutics.
Read
Medidata's corporate compliance officer and vice president of global regulatory affairs & quality assurance Earl Hulihan provides a perspective on the FDA's updated guidance on the use of computer systems in clinical research in Applied Clinical Trials.
Read
ClinPage discusses the use of reality-based budgeting to optimize protocols with Ed Seguine, Medidata general manager of trial planning solutions.
Read
Medidata Solutions' R&D head Keith Howells recognized by PharmaVOICE for industry vision.
Read
Medidata general manager of trial planning solutions Ed Seguine discusses the efficiencies of EDC and eProtocols in View on Clinical Operations.
Read
ClinPage discusses protocol optimization and EDC with Medidata's acquisition of Fast Track.
Read
Medidata and other industry thought leaders share the steps to shaping success in adaptive clinical trials in a Future Pharmaceuticals podcast.
Listen | Read
PharmaTimes reports on Medidata's new protocol development and planning tools.
Read
Bio-IT World reports on Medidata's move 'upstream' with the Fast Track acquisition.
Read
ClinPage explains how Medidata is raising the bar with its updated EDC offering.
Read
Medidata executives explain how late phase studies benefit from EDC in Applied Clinical Trials.
Read
Medidata executives provide insight on China's SFDA commitment to regulatory transparency in Bio-IT World.
Read
ClinPage reports on the INC Research and Medidata alliance.
Read
2007
Bio-IT World explains why Wyeth selected Medidata Rave as its EDC standard.
Read
Medidata vice president of Product Strategy Hugh Levaux discusses the interplay between adaptive clinical trials and e-clinical architecture on the VIEW on E-Solutions.
Read
Medidata receives rave reviews from R&D Directions. Reprinted with permission from R&D Directions, October 2007.
Read
Fast Track vice president of clinical strategy Fredric Cohen discusses the considerations for building or buying critical eClinical applications in Next Generation Pharmaceutical.
Read
Fast Track vice president of clinical strategy Fredric Cohen describes the role and importance of the clinical protocol in drug development in Next Generation Pharmaceutical.
Read
ClinPage reports on Enterprise Deal With Wyeth.
Read
Fast Track vice president of clinical strategy Fredric Cohen discusses smart clinical research protocols in the Journal of Clinical Research Best Practices.
Read
Medidata vice president of Product Strategy Hugh Levaux describes how EDC meets the needs of postmarketing research in Applied Clinical Trials.
Read
Medidata vice president of Global Regulatory Initiatives and Pharmacovigilance Bart Cobert, Ph.D., provides a contrarian's point of view on drug safety in the Food and Drug Law Journal, Volume 62, Issue 3. With permission from FDLI.
Read
Data from Fast Track confirms that more sites are asking for separate startup fees and that oncology trials are leading the way, as reported in Applied Clinical Trials.
Read
Medidata Solutions CEO and co-founder Tarek Sherif selected as PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry.
Read
Mark Uehling of ClinPage.com reveals how Medidata and statistical powerhouse SAS are raising the bar on integrations and how Medidata Rave is bringing customers closer to a complete end-to-end solution.
Read
Medidata vice president of Global Regulatory Affairs and Quality Assurance Earl Hulihan offers Five Lessons in Outsourcing in Good Clinical Practice Journal.
Read
Medidata CTO Glen de Vries discusses the role of EDC in adaptive clinical trials in the supplement to Applied Clinical Trials.
Read
Crain's New York Business tracks Medidata as one of the fastest-growing homegrown technology firms.
Read
Fast Track vice president of operations Lori Shields spotlights research fees and trends in cost-per-subject pricing in the Journal of Clinical Research Best Practices.
Read
Medidata CTO Glen de Vries discusses why EDC is not a replacement for CDMS but is the next logical evolution in PharmaVOICE.
Read
Fast Track CEO Ed Seguine explains what's different now in EHR and subject recruitment in Bioexecutive International.
Read
2006
Medidata CTO Glen de Vries examines the challenges and opportunities of managing clinical data and medical records across borders in Pharmaceutical Executive Europe.
Read
Read
Fast Track CEO Ed Seguine explains how to juggle clinical development in Next Generation Pharmaceutical.
Read
Medidata co-founder and Chief Medical Officer Ed Ikeguchi, MD, discusses "Global clinical trials: challenge or opportunity?" in Next Generation Pharmaceutical magazine.
Read
Medidata CMO Ed Ikeguchi's insight on why 'China welcomes EDC' is profiled in R&D Directions.
Read